Ovarian cancer screening in the general population
暂无分享,去创建一个
Patrice Mathevet | Guillaume Blache | P. Mathevet | L. Sabiani | Jérôme Mathis | Mohammed Amine Jellouli | Laura Sabiani | Joy Fest | J. Mathis | G. Blache | Joy Fest
[1] Steven J Skates,et al. Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.
[2] N. Urban,et al. Development of an ovarian cancer symptom index , 2007 .
[3] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[4] Matthew Burnell,et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) , 2009, Journal of Family Planning and Reproductive Health Care.
[5] E. Fung,et al. A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance. , 2010, Clinical chemistry.
[6] I. Jacobs,et al. Psychological morbidity associated with ovarian cancer screening: results from more than 23 000 women in the randomised trial of ovarian cancer screening (UKCTOCS) , 2014, BJOG : an international journal of obstetrics and gynaecology.
[7] D. Fishman,et al. Biomarkers for Early Detection of Ovarian Cancer , 2013, Women's health.
[8] R. Berkowitz,et al. Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.
[9] M. Pike,et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies , 2012, The Lancet. Oncology.
[10] D. Landsittel,et al. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. , 2006, Gynecologic oncology.
[11] K. Kinzler,et al. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers , 2013, Science Translational Medicine.
[12] A. Whittemore,et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.
[13] B. Goff,et al. Symptoms associated with ovarian cancer. , 2012, Clinical obstetrics and gynecology.
[14] D. Bowen,et al. Changes in cancer worry associated with participation in ovarian cancer screening , 2007, Psycho-oncology.
[15] B. Goff,et al. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. , 2004, JAMA.
[16] Figo Guidelines. Staging classification for cancer of the ovary, fallopian tube, and peritoneum☆ , 2013 .
[17] D. Clarke‐Pearson,et al. Screening for Ovarian Cancer , 2009 .
[18] R. Dworkin,et al. Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations , 2014, PAIN®.
[19] L. Humphrey,et al. Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians. , 2014, Annals of internal medicine.
[20] C. Crum. Intercepting pelvic cancer in the distal fallopian tube: Theories and realities , 2009, Molecular oncology.
[21] A. Berg. U.S. Preventive Services Task Force , 2004 .
[22] Nikki A. Hawkins,et al. Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. , 2012, Preventive medicine.
[23] V. Moyer,et al. Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement , 2012, Annals of Internal Medicine.
[24] O. Lapaire,et al. The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging , 2014, Archives of Gynecology and Obstetrics.
[25] A. Tinker,et al. Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers , 2013, Obstetrics and gynecology.
[26] William L. Bigbee,et al. Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[27] Jaime Prat,et al. Staging classification for cancer of the ovary, fallopian tube, and peritoneum , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[28] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[29] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[30] Robert L Coleman,et al. SGO White Paper on ovarian cancer: etiology, screening and surveillance. , 2010, Gynecologic oncology.
[31] J. Sheeder,et al. Risk-Reducing Salpingectomy as Preventative Strategy for Pelvic Serous Cancer , 2013, International Journal of Gynecologic Cancer.
[32] J. Marks,et al. Development of a multimarker assay for early detection of ovarian cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] Daniel W Chan,et al. Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. , 2007, Gynecologic oncology.
[34] S. Fegan. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) , 2009, Journal of Family Planning and Reproductive Health Care.
[35] M. Markman. Development of an ovarian cancer symptom index: Possibilities for earlier detection , 2007, Cancer.
[36] C. Johannes,et al. Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women". , 1993, American journal of epidemiology.